Showing 1-1 of 1 results
-
Drug makers play these games to keep prices high
News, Joe Nocera, Published on 15/02/2017
ยป One of my goals when I joined Bloomberg View a month ago was to dive into the contentious subject of drug pricing. I'd like to explain to readers why the pharmaceutical companies have been raising prices so relentlessly these past half-dozen years, even as the practice has become a huge issue on Capitol Hill and in the country. My friend Barry Werth, who has written two fine books about the biotech company Vertex, says the answer is simple: "Because they can." But the details of how they do it can be murky, complicated -- and sometimes underhanded.
Your recent history
-
Recently searched
-
Recently viewed links
Did you find what you were looking for? Have you got some comments for us?
